IRIS PubliCatt

Salvatore, Lisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 893
EU - Europa 331
AS - Asia 140
AF - Africa 6
Totale 1.370
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 890
IT - Italia 82
SE - Svezia 82
SG - Singapore 65
IE - Irlanda 32
DE - Germania 30
CN - Cina 28
FR - Francia 25
ID - Indonesia 24
FI - Finlandia 20
AT - Austria 19
GB - Regno Unito 10
RU - Federazione Russa 10
CI - Costa d'Avorio 6
CZ - Repubblica Ceca 6
HK - Hong Kong 6
IN - India 6
IR - Iran 6
BE - Belgio 5
RO - Romania 4
CA - Canada 3
ES - Italia 3
TH - Thailandia 2
CH - Svizzera 1
GR - Grecia 1
IL - Israele 1
KZ - Kazakistan 1
PL - Polonia 1
TR - Turchia 1
Totale 1.370
Salva come PNG Salva come JPEG
Città #
Ashburn 495
Chandler 152
Singapore 48
Dublin 32
Jakarta 24
Rome 22
New York 20
Vienna 19
Helsinki 18
Boston 17
Marseille 16
Princeton 15
Milan 13
Cattolica 10
Los Angeles 10
Beijing 9
Chicago 8
Moscow 8
Bremen 7
San Mateo 7
Wilmington 7
Abidjan 6
Hong Kong 6
Bari 5
Redmond 5
Brdo 4
Brussels 4
Kish 4
London 4
Munich 4
Washington 4
Boardman 3
Falkenstein 3
Hounslow 3
Palermo 3
Piacenza 3
Rocca Massima 3
Timisoara 3
Toronto 3
Arezzo 2
Bangkok 2
Barcelona 2
Bologna 2
Brno 2
Hyderabad 2
Lappeenranta 2
Legnano 2
Markgröningen 2
Mathura 2
Menlo Park 2
Phoenixville 2
Pune 2
Romainville 2
Seattle 2
Acton 1
Almaty 1
Amaseno 1
Andover 1
Ardabil 1
Augusta 1
Bern 1
Brooklyn 1
Cambridge 1
Comiso 1
Deva 1
Esslingen am Neckar 1
Fairfield 1
Fremont 1
Guangzhou 1
Isernia 1
Karlsruhe 1
Kilburn 1
Mechelen 1
Nanjing 1
New Orleans 1
Novokuznetsk 1
Nuremberg 1
Paris 1
Piraeus 1
Redwood City 1
Richmond 1
Saint-maur-des-fossés 1
Secaucus 1
Shanghai 1
Southwark 1
St Petersburg 1
Taizhou 1
Yardley 1
Zgierz 1
Totale 1.092
Salva come PNG Salva come JPEG
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 507
Management of single pulmonary metastases from colorectal cancer: State of the art 69
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 68
Challenges in crohn’s disease management after gastrointestinal cancer diagnosis 67
Role of chemoradiation (CRT) in the adjuvant treatment of radically resected pancreatic cancer (PC) patients (pts): a mono-institutional retrospective analysis 65
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy 59
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 57
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 53
Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients’ data from 3 phase III studies 51
Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy 44
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial 39
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 37
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers 37
Management of patients with early-stage colon cancer: Guidelines of the Italian Medical Oncology Association 35
PTEN in colorectal cancer: Shedding light on its role as predictor and target 31
Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies 28
Activity and safety of cetuximab plus modified folfoxiri followed by maintenance with cetuximab or bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer a randomized phase 2 clinical trial 26
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients 24
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer 22
Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies 18
Role of Chemoradiation in the Adjuvant Treatment of Radically Resected Pancreatic Cancer Patients: A Mono-Institutional Retrospective Analysis 17
The impact of the histological classification of ampullary carcinomas on long-term outcomes after pancreaticoduodenectomy: a single tertiary referral center evaluation 16
The role of the multidisciplinary tumor board (MDTB) in the assessment of pancreatic cancer diagnosis and resectability: A tertiary referral center experience 16
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C 15
Challenges in Crohn's Disease Management after Gastrointestinal Cancer Diagnosis 5
Totale 1.406
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.707
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 2 0 1 1 0 1 0 3 0
2020/202110 0 0 0 0 0 0 0 0 0 5 5 0
2021/2022128 7 2 0 12 3 3 2 16 4 11 35 33
2022/2023430 40 45 35 68 36 52 26 27 41 14 16 30
2023/2024750 10 48 27 22 17 38 242 255 2 14 37 38
2024/202578 12 11 55 0 0 0 0 0 0 0 0 0
Totale 1.406